Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jacquelin H. Bui"'
Autor:
Ana M. Crane, Philipp Kramer, Jacquelin H. Bui, Wook Joon Chung, Xuan Shirley Li, Manuel L. Gonzalez-Garay, Finn Hawkins, Wei Liao, Daniela Mora, Sangbum Choi, Jianbin Wang, Helena C. Sun, David E. Paschon, Dmitry Y. Guschin, Philip D. Gregory, Darrell N. Kotton, Michael C. Holmes, Eric J. Sorscher, Brian R. Davis
Publikováno v:
Stem Cell Reports, Vol 4, Iss 4, Pp 569-577 (2015)
Recently developed reprogramming and genome editing technologies make possible the derivation of corrected patient-specific pluripotent stem cell sources—potentially useful for the development of new therapeutic approaches. Starting with skin fibro
Externí odkaz:
https://doaj.org/article/3bd18eafc9e34d40b5c4fab5ff9e7a11
Autor:
Jacquelin H. Bui, Steven I. Sherman, Gilbert J. Cote, Mouhammed Amir Habra, Steven G. Waguespack, Elizabeth G. Grubbs, Michal R. Houston, Rajyalakshmi Luthra, Mimi I. Hu, Tao Hai, Meenakshi Mehrotra, Dzifa Y. Duose, Maria E. Cabanillas, Naifa L. Busaidy, Michelle D. Williams, Caitlin Evers
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 102:3591-3599
Context Interpretation of calcitonin measurement to predict the prognosis of medullary thyroid carcinoma (MTC) requires multiple measurements over an extended time period, making it an imperfect biomarker for evaluating prognosis or disease behavior.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e0902ba3f19f9c6abd2687393129d52
https://doi.org/10.1210/jc.2017-01039
https://doi.org/10.1210/jc.2017-01039
Autor:
Ken Chen, Jacquelin H. Bui, Michelle D. Williams, Gilbert J. Cote, Nancy D. Perrier, Gordon B. Mills, Roman Yelensky, Funda Meric-Bernstam, Gary A. Palmer, Elizabeth G. Grubbs, Kenneth L. Scott, Xinyan Lu, Patrick Kwok Shing Ng, Jeffrey E. Lee, Kenna R. Shaw, Hengyu Lu, Steven G. Waguespack, Naifa L. Busaidy
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 100:788-793
Oncogenic RET tyrosine kinase gene fusions and activating mutations have recently been identified in lung cancers, prompting initiation of targeted therapy trials in this disease. Although RET point mutation has been identified as a driver of tumorig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40f3410794572cc31c571a58d2679b7e
https://doi.org/10.1210/jc.2014-4153
https://doi.org/10.1210/jc.2014-4153
Autor:
Daniele Moratto, Qing Yan, Fabio Candotti, R. Michael Blaese, Linda M. Muul, Kumar Felix, Jacquelin H. Bui, Brian R. Davis, Nicole L. Prokopishyn
Publikováno v:
Clinical Immunology. 135:72-83
The reasons underlying the occurrence of multiple revertant genotypes in Wiskott-Aldrich syndrome (WAS) patients remain unclear. We have identified more than 30 revertant genotypes in a C995T WAS patient having 10-15% revertant, WAS protein (WASp)-ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32a3e10d9aafc631f762fa2820388f83
https://doi.org/10.1016/j.clim.2009.12.011
https://doi.org/10.1016/j.clim.2009.12.011
Autor:
Finn Hawkins, Xuan Shirley Li, Philipp Kramer, Wei Liao, Eric J. Sorscher, Philip D. Gregory, Darrell N. Kotton, Brian R. Davis, Jacquelin H. Bui, Wook Joon Chung, Manuel L. Gonzalez-Garay, Jianbin Wang, Helena C. Sun, David Paschon, Daniela Mora, Michael C. Holmes, Ana M. Crane, Dmitry Guschin
Publikováno v:
Molecular Therapy. 23:S74
Recently developed reprogramming and genome editing technologies make possible the derivation of corrected patient-specific pluripotent stem cell sources – potentially useful for the development of new therapeutic approaches. The primary defect in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::664f523d2b0e04d27a1b353cfe987393
https://doi.org/10.1016/s1525-0016(16)33790-x
https://doi.org/10.1016/s1525-0016(16)33790-x
Autor:
Darrell N. Kotton, Brian R. Davis, Daniela Mora, Eric J. Sorscher, Sangbum Choi, Helena C. Sun, Manuel L. Gonzalez-Garay, Finn Hawkins, Ana M. Crane, Dmitry Guschin, Wook Joon Chung, Wei Liao, Xuan Shirley Li, David Paschon, Philip D. Gregory, Jacquelin H. Bui, Philipp Kramer, Jianbin Wang, Michael C. Holmes
Publikováno v:
Stem Cell Reports, Vol 4, Iss 4, Pp 569-577 (2015)
Stem Cell Reports
Stem Cell Reports
Summary Recently developed reprogramming and genome editing technologies make possible the derivation of corrected patient-specific pluripotent stem cell sources—potentially useful for the development of new therapeutic approaches. Starting with sk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::588f8d1eaa8ac0198e879c866a3cee8a